LWCFA
GHRS icon

Loring Wolcott & Coolidge Fiduciary Advisors’s GH Research GHRS Stock Holding History

Loring Wolcott & Coolidge Fiduciary Advisors’s Portfolio GHRS Stock Details GHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2,000
Closed -$24.4K – 543
2025
Q2 		$24.4K Hold
2,000
– – ﹤0.01% 441
2025
Q1 		$19K Hold
2,000
– – ﹤0.01% 449
2024
Q4 		$17.6K Hold
2,000
– – ﹤0.01% 464
2024
Q3 		$15.1K Hold
2,000
– – ﹤0.01% 477
2024
Q2 		$23.7K Hold
2,000
– – ﹤0.01% 442
2024
Q1 		$23.4K Hold
2,000
– – ﹤0.01% 446
2023
Q4 		$15.2K Hold
2,000
– – ﹤0.01% 475
2023
Q3 		$14.1K Hold
2,000
– – ﹤0.01% 505
2023
Q2 		$23.7K Buy
+2,000
New +$20.5K ﹤0.01% 488

Other funds holding GHRS

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
JFG
Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

Loring Wolcott & Coolidge Fiduciary Advisors's GHRS Position: Q3 2025 in Review

Loring Wolcott & Coolidge Fiduciary Advisors sold out of GH Research (GHRS) in Q3 2025, closing a stake of 2,000 shares — an estimated $24.4K sold.

Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in GHRS in Q2 2023 and held it in 9 quarters. The position peaked at $24.4K in Q2 2025. 47 funds tracked by Wall St. Rank hold GHRS as of Q3 2025.

  • Loring Wolcott & Coolidge Fiduciary Advisors reported no remaining GH Research position as of Q3 2025 after selling out during the quarter.
  • Loring Wolcott & Coolidge Fiduciary Advisors sold 2,000 GH Research shares in Q3 2025, an estimated $24.4K.
  • Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in GH Research in Q2 2023 and held it in 9 quarters.
  • Loring Wolcott & Coolidge Fiduciary Advisors's GH Research position peaked at $24.4K in Q2 2025.
  • 47 funds tracked by Wall St. Rank held GH Research as of Q3 2025.

Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q3 2025, filed 24 Oct 2025.